[144] Beam Therapeutics Inc. SEC Filing
Rhea-AI Filing Summary
BEAM affiliate submitted a Form 144 notice proposing the sale of 20,000 shares of Common Stock. The filing lists the disposition method as Restricted Stock Vesting with an issuer-related transfer dated 03/31/2026. Recent reported sales by the same holder include $33,978.85 for 1,254 shares on 01/02/2026, $644,830.68 for 18,629 shares on 01/15/2026, and $46,614 for 1,371 shares on 01/22/2026. The cover records 101,856,245 shares (as of 04/02/2026).
Positive
- None.
Negative
- None.
Insights
Form 144 reports an affiliate's planned resale of vested restricted stock.
The filing lists a proposed sale of 20,000 shares tied to restricted stock vesting on 03/31/2026. Form 144 is a notice required under Rule 144 when affiliates intend to resell restricted or control securities; it does not itself execute a sale.
Cash‑flow treatment and timing are not specified here; subsequent brokered transactions or a Form 4/5 would show completed trades and final proceeds. Future filings will clarify whether these shares are sold on the open market or via another distribution method.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Vesting financial
Issuer financial